Ginsenoside Rh2

Inhibition of prostatic cancer growth by ginsenoside Rh2

Inhibition of prostatic cancer growth by ginsenoside Rh2

Prostate cancer develops in the prostate, which is a gland in the male reproductive system. Prostate cancers generally grow slowly. However, aggressive prostate cancers do occur, which are capable of […]

EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2

EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2

Glioblastoma multiforme (GBM) is the most malignant primary human brain cancer and cannot be cured by any therapy available today. Current therapy includes complex treatments of neurosurgical resection, radiotherapy, and […]